[Hemodynamic properties of two new phthalazine derivatives.]

[Hemodynamic properties of two new phthalazine derivatives.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Hemodynamic properties of two new phthalazine derivatives.] Abstract Text:

A SCHMID,F REUBI,

[Hemodynamic properties of two new phthalazine derivatives.] Publishing Authors By Initials

A SCHMID,F REUBI,

For similar cardiovascular system research abstracts see: cardiovascular system research

PUBMED ID PMID:

MEDLINE DATE:

[Hemodynamic properties of two new phthalazine derivatives.] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Helvetica medica acta

VOLUME: 17

Page Numbers: 543-6

Journal Abbreviation:

ISSN: 0018-0203

DAY: 24

MONTH: Oct

YEAR: 1950

[Hemodynamic properties of two new phthalazine derivatives.] Information

Number of References:

LANGUAGE: und

NlmUniqueID: 401174

[Hemodynamic properties of two new phthalazine derivatives.] Keywords Mesh Terms:

KEYWORDS: Cardiovascular System

MESH TERMS:

Chemical & Substance for Abstract: [Hemodynamic properties of two new phthalazine derivatives.] Information

Substance Name: phthalazine

Registry Number: 253-52-1

Grant and Affiliation Information for [Hemodynamic properties of two new phthalazine derivatives.]

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Helv Med Acta

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Hemodynamic properties of two new phthalazine derivatives Related Publications

• Blood pressure, circulating renin and the body sodium/volume state in patients with mild renal failure.
• CRF receptors in the rodent and human cardiovascular systems: species differences.
• GPR87 is an overexpressed G-protein coupled receptor in squamous cell carcinoma of the lung.
• Haemodynamic and blood volume studies in long-term haemodialysis patients, and in patients with successfully transplanted kidneys.
• Not Available
• Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms.
• Peptide receptor expression in GEP-NET.
• Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.
• Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma.
• The effect of cochlear nerve lesion on the release of glutamate, aspartate, and GABA from cat cochlear nucleus, in vitro.
• Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue.
• [ALDOMET IN THE AMBULATORY TREATMENT OF HYPERTENSION. PERSONAL EXPERIENCES AND STUDIES ON RENAL HEMODYNAMICS.]
• [Are the so-called cerebroactive drugs really useful?]
• [Conservative therapy of chronic renal failure]
• [Exchangeable sodium, fluid space and hypertonia in chronic uremia]
• [Hemodynamic properties of two new phthalazine derivatives.]
• [Immunosuppression]
• [Importance of Kaplan's hypertension testing the etiologic diagnosis of hypertension]
• [Kidney function and antibiotic dosage]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Practical recommendations for antihypertensive therapy (author's transl)]
• [The behavior of renal hemodynamics in hydroxydione anesthesia.]
• [The classification of glomerulonephritis (author's transl)]
• [The present status of treatment of chronic renal insufficiency.]
• [Therapeutic tests and "ex juvantibus" diagnosis (author's transl)]
• [Treatment of circulatory collapse and shock.]
• [What the general practitioner should know about electrolytes.]